A recent paper reported that tumor STC1 inhibits APC phagocytosis and contributes to tumor immune evasion and immunotherapy resistance (Lin et al., 2021), indicating a role for STC1 in the immune response, which provides a possible reason to explain why STC1 functions differently in vivo and in vitro. This evidence concerns the gene STC1 and neoplasm.